WELTRUZA (monthly olanzapine injection)
FDA-approved monthly subcutaneous olanzapine for adults with schizophrenia—a delivery option, not a proven improvement over every oral treatment.
TREATMENT & SUPPORT EXPLORER
Therapies, medications, care models, brain stimulation, devices, supplements and life supports. Every option is labeled by evidence for a specific use—never one label for everything.
Explore promising new approaches without mistaking early studies or marketing for proven care. Each option is assessed for its particular use and population.
Filter by condition, approach and evidence status, then save worthwhile questions to your care plan.
55 options
FDA-approved monthly subcutaneous olanzapine for adults with schizophrenia—a delivery option, not a proven improvement over every oral treatment.
Selective dopamine D1 antagonist with promising randomized pediatric tic findings; under FDA Priority Review, not yet approved.
Investigational adjunct for treatment-resistant schizophrenia; FDA clinical hold at US study sites after a potential cardiac safety signal.
Experimental psychedelic drug under early-phase trial planning for PTSD and opioid use disorder; not FDA approved and associated with dangerous heart-rhythm risks.
Defined medicines have specific approved uses. Anxiety, OCD and autism-related research remains limited or mixed; psychiatric risks matter.
A Tourette research pathway with encouraging trial findings; the current wellness release is distinct from medical-device approval.
EMDR can be considered for PTSD in an autistic adult after individualized assessment; it does not treat autism itself.
The specialized form of CBT at the center of evidence-based OCD care.
A behavioral therapy that teaches tic awareness, competing responses and ways to manage situations that worsen tics.
Structured therapy for generalized anxiety, panic, social anxiety and phobias, often including gradual exposure.
Talking therapies that change unhelpful thinking and rebuild meaningful activity.
Structured help with organization, planning, procrastination and the patterns ADHD tends to create.
Coaching parents in specific, positive strategies that reduce challenging behavior and stress at home.
The recommended first treatment for chronic insomnia in adults—not just 'sleep hygiene'.
Structured therapies designed specifically to process trauma and reduce PTSD symptoms.
Skills-based therapy for intense emotions, impulsive behavior and self-harm.
Specialist therapies for anorexia, bulimia and binge-eating disorder.
Therapy that helps people make sense of and cope with distressing experiences like voices or unusual beliefs.
Structured sessions that help families understand the condition, communicate and plan for relapse together.
Team-based early psychosis care—the recommended approach soon after psychosis begins.
A multidisciplinary team that brings care to the person in the community, for those with the highest needs.
Help finding, getting and keeping a real job—matched to the person, with ongoing support.
Regular, organized activities with support built in—for friendship, confidence and somewhere to belong.
Small groups that practice conversation, friendships and handling conflict—for people who want that.
Practical help with daily living, sensory needs, motor skills and participation at home, school and work.
Support for communication—including augmentative and alternative communication for people with limited speech.
Practical accountability and systems for planning, routines and getting things done.
Paid help that gives caregivers a break and helps the person build a more independent life.
Among the most-studied treatments in psychiatry; chosen and monitored by a prescriber.
Options when stimulants aren’t suitable, aren’t tolerated or aren’t enough.
Established medicines for depression, several anxiety disorders and OCD—each for specific indications.
The core of long-term bipolar treatment, chosen and monitored by a psychiatrist.
Central to treating psychosis and schizophrenia; also used for mania, autism-related irritability and severe tics.
A rapid-acting prescription treatment for treatment-resistant depression, given in certified clinics.
Offered by some clinics for depression; differs from esketamine in regulatory status and evidence.
Noninvasive magnetic pulses to specific brain areas—established for depression, cleared for OCD, experimental elsewhere.
Patterned TMS: established depression uses and a separate, emerging OCD evidence base. The exact protocol matters.
A highly effective treatment for severe depression and catatonia, given under anesthesia.
Surgically implanted devices reserved for severe, treatment-resistant situations.
A prescription device worn at night that stimulates a nerve in the forehead.
Regulated software treatments—different from general wellness apps.
Training brain-wave patterns with real-time feedback; widely marketed, evidence mixed.
Supports mood, sleep and health; a treatment option for some depression and a helpful add-on elsewhere.
Poor sleep worsens almost everything—and often has treatable causes.
A sleep-timing hormone sold over the counter in the US; evidence depends on the sleep problem and the person.
Widely discussed for ADHD and mood; effects in studies are small and inconsistent.
Correcting a documented deficiency is established; using iron for ADHD symptoms is not.
Correcting deficiency matters for health; claims that it treats autism are not established.
Useful when someone is deficient; evidence for ADHD symptoms is limited.
Studied for OCD-related conditions and autism irritability; results are mixed.
An active research area; not an established treatment for autism or mental-health conditions.
Frequently searched options with very different—and mostly early—evidence. Each has its own brief.
Not recommended—no benefit for autism and real risk of serious harm.
Not recommended for core autism features; medical dietary needs are a separate question.
Not recommended for autism.